Informally known as the Hatch-Waxman Act, is a 1984 US federal law which encourages the manufacture of generic drugs by the pharmaceutical industry. The Act provides some protection for drug innovators while facilitating and providing incentives for companies to file ANDAs. Representative Henry Waxman of California and Senator Orrin Hatch of Utah sponsored the act.